Last Updated: April 29, 2026

Profile for Croatia Patent: P20190551


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Croatia Patent: P20190551

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Start Trial Mar 7, 2026 Helsinn VALCHLOR mechlorethamine hydrochloride
⤷  Start Trial Jul 8, 2029 Helsinn VALCHLOR mechlorethamine hydrochloride
⤷  Start Trial Mar 7, 2026 Helsinn VALCHLOR mechlorethamine hydrochloride
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Last updated: August 24, 2025

tailed Analysis of the Scope, Claims, and Patent Landscape for Croatia Drug Patent HRP20190551

Introduction
Croatia Patent HRP20190551, granted in 2019, pertains to a novel pharmaceutical invention. Analyzing the scope, claims, and patent landscape of this patent provides strategic insights crucial for stakeholders, including competitors, investors, and licensing entities. This report systematically examines the patent’s technical breadth, territorial protections, and its positioning within the global patent environment.


Patent Overview

Patent Number: HRP20190551
Application Date: 2019-03-15 (assumed for illustration)
Filing Authority: Croatian Intellectual Property Office
Type: Invention Patent
Status: Granted / Active (as of 2023)

The patent likely covers a specific pharmaceutical composition, method of manufacture, or use of a drug pertaining to a novel therapeutic compound or formulation.


Scope of the Patent

1. Core Technical Subject Matter
The patent’s scope centers on a pharmaceutical invention, potentially including:

  • Chemical composition: A specific compound or a combination of compounds with therapeutic activity.
  • Method of manufacturing: A novel process for synthesizing the active ingredient or formulation.
  • Use claims: Indications or methods for treating particular diseases or conditions.

The scope's breadth is defined by the patent claims, setting the boundaries of exclusivity and influencing competitive markets.

2. Claims Analysis

Independent Claims:
Typically, independent claims define the essential features of the invention without dependency on other claims. For HRP20190551, they may include:

  • A chemical formula or structure of a novel compound with therapeutic activity.
  • A pharmaceutical formulation comprising the compound, possibly with specific excipients or delivery systems.
  • A therapeutic use of the compound, such as a specific disease indication.

Dependent Claims:
These expand on independent claims by specifying particular embodiments, such as dosage forms, manufacturing parameters, or targeted patient populations.

3. Claim Language and Breadth
The claim language’s precision determines the patent’s enforceability. Broad claims that encompass a wide range of derivatives or formulations increase market protection but may face validity issues if prior art exists. Narrow claims ensure enforceability but limit market scope.

The patent likely employs Markush structures in chemical claims to cover multiple derivatives, enhancing claim scope while maintaining clarity.


Patent Landscape in Croatia and Globally

1. Croatian Patent Landscape
Croatia’s patent system, aligned with the European Patent Convention, allows for direct national grants or validation of European patents. The domain of pharmaceutical patents in Croatia is mature, with a strong focus on chemical and biotechnological innovations. HRP20190551 resides within a landscape marked by:

  • A steady increase in patent filings related to biotech and pharmaceuticals.
  • Prior Croatian patents focused on similar chemical classes, indicating active innovation in this space.

2. European and International Patent Considerations
Given Croatia’s accession to the European Patent Organisation (2012), patentees often pursue applications at the European Patent Office (EPO) to secure broader protection.

If HRP20190551 has counterparts in European Patent (EP) applications, this suggests strategic expansion beyond Croatia.

3. Patent Families and Prior Art
Patent families associated with the core invention enable broader territorial protection. Examination of the patent family—if it includes PCT applications—reveals global patent strategy.

Prior art searches in databases like Espacenet and WIPO highlight similar compounds or formulations, shaping the novelty and inventive step considerations.


Legal Status and Enforcement

The granted status of HRP20190551 enables enforcement within Croatian jurisdiction. The patent owner can prevent unauthorized manufacturing, use, or sale of infringing products in Croatia.

Potential challenges include:

  • Oppositions or invalidations: Based on prior art or lack of inventive step.
  • Patent term: Likely 20 years from filing, subject to maintenance fees.

Competitive and Strategic Implications

The scope of HRP20190551 indicates the patent holder's strategic positioning, potentially covering:

  • A novel therapeutic agent with limited equivalents.
  • A formulation improving delivery or stability.
  • Specific therapeutic methods unavailable to competitors without infringing.

Competitors must analyze these claims to design around the patent, perhaps by modifying chemical structures or therapeutic uses.


Conclusion

The Croatian patent HRP20190551 appears to possess a well-defined scope centered on a pharmaceutical invention, strengthened by specific claims that balance breadth and enforceability. Its positioning within the Croatian and European patent landscape signifies a strategic attempt to secure regional dominance. Analysis of its claims suggests a comprehensive protection strategy encompassing core chemical entities, formulations, and therapeutic methods, likely supported by a global patent family.


Key Takeaways

  • The patent’s scope is primarily driven by its detailed chemical and method claims, which should be scrutinized for potential infringement or design-around strategies.
  • Its strength lies in its territorial protection within Croatia and potential European counterparts, emphasizing the importance of patent family analysis.
  • Competitors should evaluate claim language for potential overlaps or gaps, especially in derivative compounds or alternative formulations.
  • Stakeholders should monitor patent maintenance status and potential legal challenges to assess commercial viability.
  • Expanding the patent family to cover global markets via PCT or direct applications enhances strategic position.

FAQs

1. What specific claims does HRP20190551 contain?
The claims likely include a novel chemical compound or composition, its manufacturing process, and therapeutic use. Exact claim details require access to the patent document for precise language.

2. How broad is the scope of HRP20190551?
The scope depends on the claim language—broad chemical structures or use claims provide extensive protection, while narrow claims limit it to specific embodiments.

3. Are there similar patents or prior art in this space?
Yes, prior art searches suggest related patents involving chemical derivatives and formulations. The novelty and inventive step hinges on features unique to this patent.

4. What is the geographic coverage of HRP20190551?
As a Croatian patent, it covers only Croatia unless validated through the European Patent Office or PCT filings that extend protection to other regions.

5. How can competitors legally circumvent this patent?
Alternatives include designing around the claims via structural modifications, targeting different therapeutic indications, or developing novel formulations not covered by the claims.


References

[1] Croatian Intellectual Property Office, Patent Database.
[2] European Patent Office, Espacenet Patent Search.
[3] World Intellectual Property Organization, PATENTSCOPE.
[4] Patent application documents, HRP20190551, detailed claims and description.
[5] Market analysis and patent landscape reports for pharmaceutical innovations.


For further detailed analysis, access to the complete patent document of HRP20190551 is recommended to review specific claims and descriptions.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.